Literature DB >> 23368433

Tackling the elusive challenges relevant to conquering the 100-plus year old problem of Alzheimer's disease.

Luis V Colom1, George Perry, Rodrigo O Kuljis.   

Abstract

Despite over one hundred years of intense effort studying Alzheimer's disease (AD), we still do not understand its cause(s) and this adversely affects our ability to develop strongly effective treatments and means to prevent it. This is because our research efforts are not aligned to decipher this age-related disorder that, well after its discovery, has become a major cause of death throughout the world. We are therefore recommending a process to analyze some of the principal factors that hinder our progress in this field of research. Recognizing these barriers - and acting on such a recognition by seeking to resolve them experimentally and garnering societal support to do so - will constitute critical steps towards establishing strategies that will lead to a sorely needed paradigm shift in AD research, and ultimately to the prevention and the effective treatment of this devastating condition. This will probably also spur progress in many related neuropsychiatric disorders, and in that sense act as a seminal endeavor with far-reaching consequences. In order to accomplish this complex task, the biomedical community must acknowledge and come to a consensus about the factors that limit our progress, and then work together to generate new algorithms to tackle these fundamental issues rationally, effectively and deliberately.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23368433     DOI: 10.2174/1567205011310010015

Source DB:  PubMed          Journal:  Curr Alzheimer Res        ISSN: 1567-2050            Impact factor:   3.498


  4 in total

1.  Rapidly progressive Alzheimer's disease features distinct structures of amyloid-β.

Authors:  Mark L Cohen; Chae Kim; Tracy Haldiman; Mohamed ElHag; Prachi Mehndiratta; Termsarasab Pichet; Frances Lissemore; Michelle Shea; Yvonne Cohen; Wei Chen; Janis Blevins; Brian S Appleby; Krystyna Surewicz; Witold K Surewicz; Martha Sajatovic; Curtis Tatsuoka; Shulin Zhang; Ping Mayo; Mariusz Butkiewicz; Jonathan L Haines; Alan J Lerner; Jiri G Safar
Journal:  Brain       Date:  2015-02-15       Impact factor: 13.501

2.  Distinct prion-like strains of amyloid beta implicated in phenotypic diversity of Alzheimer's disease.

Authors:  Mark Cohen; Brian Appleby; Jiri G Safar
Journal:  Prion       Date:  2016       Impact factor: 3.931

Review 3.  Biological basis for cerebral dysfunction in schizophrenia in contrast with Alzheimer's disease.

Authors:  Rodrigo O Kuljiš; Luis V Colom; Leonel E Rojo
Journal:  Front Psychiatry       Date:  2014-02-03       Impact factor: 4.157

Review 4.  Implications of prion adaptation and evolution paradigm for human neurodegenerative diseases.

Authors:  M Enamul Kabir; Jiri G Safar
Journal:  Prion       Date:  2014 Jan-Feb       Impact factor: 3.931

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.